Sunday, November 30, 2025 4:23:13 PM
I think that it is fair to say that there was a much heralded 'special relationship' between NWBO, Vested Clinical Interests & the Regulator in the early days.
Because the MHRA lacked the expertise in this emerging scientific field, they very much allowed the tail to wag the dog.
And it was under these circumstances that NWBO tried to BS their way to approval, hence the 1m + pages of pure speculative waffle, simply relying on the Regulator's ignorance (bull shit baffles brains).
Fortunately, due to changes at the top, a new set of un-invested, reputation wise, eyes, took a fresh look at the application and the nature of the company behind it.
In tandem to this, third parties oversaw their own audit of matters.
You'll note that LP is just wringing out the last bit of value out of the company, leaving investors with next to zero.
You also see that the Regulator is now putting in new legislation and procedures, checks & balances for this field of potential treatments now, so that this type of attempted fraud cannot ever happen again.
Because the MHRA lacked the expertise in this emerging scientific field, they very much allowed the tail to wag the dog.
And it was under these circumstances that NWBO tried to BS their way to approval, hence the 1m + pages of pure speculative waffle, simply relying on the Regulator's ignorance (bull shit baffles brains).
Fortunately, due to changes at the top, a new set of un-invested, reputation wise, eyes, took a fresh look at the application and the nature of the company behind it.
In tandem to this, third parties oversaw their own audit of matters.
You'll note that LP is just wringing out the last bit of value out of the company, leaving investors with next to zero.
You also see that the Regulator is now putting in new legislation and procedures, checks & balances for this field of potential treatments now, so that this type of attempted fraud cannot ever happen again.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
